Radiofrequency ablation for benign thyroid nodules in LatinX patients
Official title: Study of the Use of Radiofrequency Ablation in LatinX Patients With Symptomatic Benign Thyroid Nodules
Run by Northwell Health · NCT05903196 · Data updated 2026-11-12
This study is testing if a new, less invasive treatment called radiofrequency ablation can safely help LatinX patients with bothersome benign thyroid nodules feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 44 (estimated) |
| Sponsor | Northwell Health Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | March 12, 2024 |
| Main results expected | December 1, 2029 |
| Study ends | December 30, 2029 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT05903196 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are LatinX individuals over 18 years old with benign, symptomatic thyroid nodules that meet specific ultrasound criteria.
✕Probably not a fit
Patients with malignant nodules, those who are pregnant or breastfeeding, or individuals with certain medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the use of radiofrequency ablation (RFA) as a minimally invasive treatment for benign symptomatic thyroid nodules in LatinX patients. Traditionally, surgery was the primary treatment option, but RFA offers a safer alternative that can be performed in a clinic setting without the risks associated with surgery. Participants will undergo the RFA procedure and will be monitored for effectiveness and side effects over 18 months. The study aims to determine if RFA is a safe and effective option for this specific population, which has not been extensively studied before.
Why it matters
Potential benefit: If successful, this treatment could provide a safer, non-surgical option for LatinX patients suffering from symptomatic benign thyroid nodules.
How similar studies have gone: While evidence supporting RFA for thyroid nodules exists internationally, this specific study focusing on LatinX patients is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject capable of giving informed consent * Stated willingness to comply with all study procedures and availability for the duration of the study * Subjects over 18 years of age * Subject who self-identifies as LatinX * Subjects who have a benign, symptomatic thyroid nodule * Subjects whose nodule has well-defined margin on ultrasound and is surrounded by at least 2mm of normal thyroid parenchyma in all directions Exclusion Criteria: * Patients who are pregnant, trying to become pregnant, or breastfeeding * Patient who have a cardiac pacemaker,defibrillator , or other electromedical equipment * Patients who have a nodule that is malignant or not predominantly solid (must be \>50% solid by ultrasound) * Patients who cannot give consent * Patients on anticoagulation or dual antiplatelet therapy * Patients with acute illness * People with BP \> 140/90 prior to the scheduled procedure
Where it's running
-
Northwell Health Physician Partners
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Daniel Kuriloff, MD — Northwell Health
- Study coordinator: Karina Ziskovich, BBA
- Email: kziskovich@northwell.edu
- Phone: 212-434-3715
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NIRAF-guided identification of parathyroids during thyroidectomy
A wearable near-infrared autofluorescence device is being tested to help surgeons find and protect the parathyroid glands during thyroid surgery in adults.
-
Combining ultrasound and cytology whole-slide images to predict cancer risk in indeterminate (Bethesda III) thyroid nodules
This project will test whether a deep learning model that merges ultrasound pictures and cytology whole-slide images can better predict which Bethesda III thyroid nodules are cancerous.
-
Low calcium after thyroid removal
This project will see if clinical, lab, and surgical factors predict low calcium after thyroid surgery in adults treated at Minia University Hospital from 2014–2024.
-
Active monitoring for small Bethesda IV thyroid nodules
This program will try active monitoring with scheduled ultrasounds and clinic visits instead of immediate surgery for adults with a single Bethesda IV thyroid nodule under 2 cm.
-
Multiparametric ultrasound imaging for pancreatic risk screening and thyroid nodules
This project will try multiparametric ultrasound (mpUS) to see if it gives clearer pictures of pancreatic tissue for people at high risk for pancreatic cancer and of thyroid nodules for people being evaluated for those lumps.
-
Using radiofrequency ablation to treat low-risk thyroid cancer
This study is testing if a new treatment called radiofrequency ablation can safely help people with low-risk thyroid cancer that is 2 cm or smaller instead of traditional surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.